- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01001039
Validation of the Facial and Cephalic Pain Inventory (FACE PAIN)
Validation of the FAcial and CEphalic PAin INventory (FACE PAIN)
Study Overview
Status
Conditions
Detailed Description
The following specific aims will be addressed:
- to create a user-friendly, self-explanatory instrument (FACE PAIN questionnaire) with pain severity visual analog scales associated with the common locations of facial pain in chronic sinusitis.
- to evaluate the clinimetric reliability and validity of the FACE PAIN questionnaire
- to evaluate the ability of th FACE PAIN questionnaire to detect change in symptoms following medical or surgical treatment
- to quantify a minimally important difference in the FACE PAIN instrument by correlating disease-specific quality of life change (Transition Scale) with FACE PAIN rating changes following treatment.
- to evaluate the correlation between facial pain symptoms described on the FACE PAIN questionnaire with CT scan and endoscopic findings.
The measurements used for the study are: demographics (age, gender and race), contact information (to facilitate mailing of future instruments), Sinonasal Outcome Test-20 (SNOT-20 - a well validated, 20-item measure of rhinosinusitis specific QOL), FAcial and CEphalic PAin INventory (instrument under study) and Translational Quality of Life Form (this transition scale provides a subjective quantification of the degree of change in quality of life from sinusitis); CT scans and nasal endoscopy findings.
Control subjects will complete the SNOT-20 (validated QOL form) and the FACE PAIN a single time.
Case subjects will complete the SNOT-20 and the FACE PAIN questionnaire at the visit during which they review their CT results with the MD. Thereafter, they will complete the FACE PAIN questionaire twice more; at weeks 12 and 14 post that visit. They will also complete the Transition Scale at week 12. These forms will be mailed to the subjects and returned by mail.
We hypothesize that facial pain ratings will correlate moderately with SNOT-20 scores and a transition scale. Higher values are not expected because QOL instruments encompass many symptoms of chronic sinusitis, but the FACE PAIN instrument addresses location and severity of pain.
We will also test the hypothesis that facial pain ratings will be much lower in non-sinusitis patients.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington Rhinology Clinic
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Case subjects from the Rhinology Clinic must have CT evidence of chronic sinusitis
- Control subject from the Otology Clinic who have not had sinus surgery in the past 2 months
Exclusion Criteria:
- any subject unable to give informed consent of complete self-administered questionnaires written in English
- Control subjects with a history of sinusitis in the last 6 months
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
|---|
|
control
Patients seen in the Otology clinic who have not had sinus surgery in the past 2 months or a history of sinusitis in the last 6 months.
|
|
cases
Patients seen in the Rhinology Clinic with a complaint of facial pain.
They must have evidence of chronic sinusitis.
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 37055-E/A
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sinusitis
-
Loma Linda UniversityWithdrawnChronic Sinus Disease | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Maxillary Bilateral | Chronic Sinusitis - Frontoethmoidal
-
LifeBridge HealthUnknownChronic Sinusitis | Nasal Polyps | Chronic Sinusitis, Ethmoidal | Chronic Sinusitis, Sphenoidal | Chronic Sinusitis - Frontoethmoidal | Chronic Sinusitis - Ethmoidal, Posterior | Chronic Sinusitis - Ethmoidal Anterior | Nasal Polyp - PosteriorUnited States
-
Assiut UniversityNot yet recruitingDeviated Nasal Septum Effect on Maxillary Sinus Volumes and Development of Maxillary Sinusitis by CTDeviated Nasal Septum and Maxillary Sinusitis
-
Tampere University HospitalRecruitingMaxillary Sinusitis | Eustachian Tube Dysfunction | Sinusitis, Chronic | Sinusitis RecurrentFinland
-
Collin County Ear Nose & ThroatIntersect ENTCompletedChronic Sinusitis, EthmoidalUnited States
-
STS MedicalNot yet recruitingChronic Sinusitis, Ethmoidal
-
Ayu, Inc.CompletedSinusitis | Rhinosinusitis | Chronic Rhino-sinusitisMalaysia
-
Deraya UniversityCompleted
-
St. Louis UniversityTerminatedStent | Sinusitis, FrontalUnited States
-
Shanghai Yidian Pharmaceutical Technology Development...RecruitingChronic Sinusitis Without Nasal PolypsChina